← Browse by Condition
Medical Condition

cognitive impairment

Total Trials
22
Recruiting Now
22
Trial Phases
Phase 4, Phase 2

ClinicalMetric tracks all active clinical trials for cognitive impairment sourced from ClinicalTrials.gov. Each listing includes the NCT identifier, current recruitment status, phase, primary endpoints, sponsor, estimated enrollment, and participating countries — updated daily as new studies open and status changes.

  • Recruiting trials currently enrolling participants, with eligibility criteria and age requirements
  • Phase 1–4 studies from early safety trials to post-marketing surveillance
  • NIH, pharmaceutical sponsor, and academic medical center studies worldwide
  • AI-powered plain-language summary available for every trial listing

Frequently Asked Questions — cognitive impairment Clinical Trials

How many clinical trials are currently recruiting for cognitive impairment?
ClinicalMetric currently tracks 22 actively recruiting clinical trials for cognitive impairment, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 22. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for cognitive impairment?
cognitive impairment research spans Phase 2 (1 trial), Phase 4 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a cognitive impairment clinical trial?
Eligibility criteria for cognitive impairment trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 2
1
Phase 4
1
Top Sponsors
Mayo Clinic 1 trial
Kessler Foundation 1 trial
Sunnybrook Health Sciences Centre 1 trial
Zhejiang University 1 trial
Istituto Auxologico Italiano 1 trial

Recruiting Clinical Trials

NCT06020703
Recruiting

A Study of Healthy Microbiome, Healthy Mind

Enrollment
40 pts
Location
United States
Sponsor
Mayo Clinic
View Trial →
NCT06238492
Recruiting

A Pilot RCT to Improve Cognitive Processing Speed in Acute SCI

Enrollment
24 pts
Location
United States
Sponsor
Kessler Foundation
View Trial →
NCT05114876
Recruiting

Redesigning the Surgical Pathway (PROMoTE)

Enrollment
260 pts
Location
Canada
Sponsor
Sunnybrook Health Sciences Cen...
View Trial →
NCT05886114
Recruiting

A Multi-domain Lifestyle Intervention Among Aged Community-residents in Zhejiang, China

Enrollment
1,200 pts
Location
China
Sponsor
Zhejiang University
View Trial →
NCT06312956
Recruiting

Multidimensional Evaluation of Patients' Affected by Obstructive Apnea Syndrome (OSAS) Before and After Ventilotherapy

Enrollment
65 pts
Location
Italy
Sponsor
Istituto Auxologico Italiano
View Trial →
NCT06466460
Recruiting

Motion-based Interactive Technology for Improved Quality of Life in Individuals With Cognitive Impairment

Enrollment
60 pts
Location
Sweden
Sponsor
Marie Matérne
View Trial →
NCT06596746
Recruiting

Neurodegenerative Diseases Progression Markers (MARKERS-NDD)

Enrollment
600 pts
Location
Italy
Sponsor
Casa di Cura San Raffaele Cass...
View Trial →
NCT04722939
Recruiting

Neurocognitive Outcomes for ICU Patients With Acute Kidney Injury

Enrollment
104 pts
Location
Canada
Sponsor
Dr. Gordon Boyd
View Trial →
NCT03810794
Recruiting

Clinical Evaluation on the Therapeutic Effect of Acupuncture Treatment for Alzheimer's Disease

Enrollment
180 pts
Location
China
Sponsor
Jian Pei,MD
View Trial →
NCT06223672
Recruiting

Essential Fats For Enhancing Cognitive Thinking (EFFECT) Study

Enrollment
88 pts
Location
United States
Sponsor
Ohio State University
View Trial →
NCT06652828
Recruiting

Perturbation-Based Treadmill Training to Prevent Unrecovered Falls in Geriatric Patients

Enrollment
396 pts
Location
Germany
Sponsor
University of Oldenburg
View Trial →
NCT07250789
Recruiting

Cognitive Screening and Multidomain Intervention Targeting Cognitive Decline in Type 2 Diabetes (The Brain Care Study)

Enrollment
420 pts
Location
Denmark
Sponsor
Steno Diabetes Center Copenhag...
View Trial →
NCT06709898
Recruiting

Stroke in Working Age and Job Accommodation in Facilitating Transition Back to Work

Enrollment
100 pts
Location
Finland
Sponsor
Finnish Institute of Occupatio...
View Trial →
NCT06043765
Recruiting

Reducing Cognitive Impairment in Glioma with Repetitive Transcranial Magnetic Stimulation and Cognitive Strategy Training

Enrollment
16 pts
Location
Netherlands
Sponsor
Linda Douw
View Trial →
NCT05877196
Recruiting

A SMART Trial of Adaptive Exercises to Optimize Aerobic-Fitness Responses

Enrollment
216 pts
Location
United States
Sponsor
Arizona State University
View Trial →
NCT06518824
Recruiting

Theta Deep Brain Stimulation for Cognitive Enhancement in Parkinson's Disease

Enrollment
27 pts
Location
Canada
Sponsor
University of British Columbia
View Trial →
NCT04027244
Recruiting

Leg Ischaemia Management Collaboration

Enrollment
420 pts
Location
United Kingdom
Sponsor
University of Leicester
View Trial →
NCT05980117 Phase 4
Recruiting

Remimazolam for Cataract Surgery

Enrollment
120 pts
Location
United States
Sponsor
University of California, Los ...
View Trial →
NCT07512739
Recruiting

A Sitting Tai Chi Programme for Chronic Stroke Survivors With Post-stroke Cognitive Impairment

Enrollment
176 pts
Location
China
Sponsor
Chinese University of Hong Kon...
View Trial →
NCT06592352 Phase 2
Recruiting

MODAFIMS: A Trial to Evaluate Predictors of Response to MODAFinil in Patients With Multiple Sclerosis

Enrollment
64 pts
Location
Portugal
Sponsor
Clinical Academic Center (2CA-...
View Trial →
NCT02795052
Recruiting

Neurologic Stem Cell Treatment Study

Enrollment
500 pts
Location
United States, Unite...
Sponsor
MD Stem Cells
View Trial →
NCT06482749
Recruiting

Repetitive Transcranial Magnetic Stimulation and Postoperative Neurocognitive Recovery

Enrollment
568 pts
Location
China
Sponsor
Peking University First Hospit...
View Trial →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology